[HTML][HTML] Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, JP Moore - Elife, 2020 - elifesciences.org
We review aspects of the antibody response to SARS-CoV-2, the causative agent of the
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization.
PJ Klasse, JP Moore - Elife, 2020 - europepmc.org
We review aspects of the antibody response to SARS-CoV-2, the causative agent of the
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization.
PJ Klasse, JP Moore - 2020 - cabidigitallibrary.org
We review aspects of the antibody response to SARS-CoV-2, the causative agent of the
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
[PDF][PDF] Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, JP Moore - pdfs.semanticscholar.org
We review aspects of the antibody response to SARS-CoV-2, the causative agent of the
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, JP Moore - 2020 - agris.fao.org
We review aspects of the antibody response to SARS-CoV-2, the causative agent of the
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, JP Moore - eLife, 2020 - cir.nii.ac.jp
抄録< jats: p> We review aspects of the antibody response to SARS-CoV-2, the causative
agent of the COVID-19 pandemic. The topics we cover are relevant to immunotherapy with …
agent of the COVID-19 pandemic. The topics we cover are relevant to immunotherapy with …
[HTML][HTML] Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, JP Moore - eLife, 2020 - ncbi.nlm.nih.gov
We review aspects of the antibody response to SARS-CoV-2, the causative agent of the
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, JP Moore - eLife, 2020 - go.gale.com
We review aspects of the antibody response to SARS-CoV-2, the causative agent of the
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
Antibodies to SARS-CoV-2 and Their Potential for Therapeutic Passive Immunization
PJ Klasse, JP Moore - 2020 - preprints.org
We review aspects of the antibody response to SARS-CoV-2, the causative agent of the
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, JP Moore - eLife, 2020 - pubmed.ncbi.nlm.nih.gov
We review aspects of the antibody response to SARS-CoV-2, the causative agent of the
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …
COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from …